- Stocks
- Healthcare
- NASDAQ: INCY

Price (delayed)

$55.43

Market cap

$12.42B

P/E Ratio

29.33

Dividend/share

N/A

EPS

$1.89

Enterprise value

$9.23B

Incyte Corp is an American pharmaceutical company based in Alapocas, Delaware. The company was founded in Palo Alto, California in 1991 and went public in 1993. Incyte has one drug,

INCY's P/E is 33% below its 5-year quarterly average of 43.4 and 32% below its last 4 quarters average of 42.6

INCY's equity is up by 17% year-on-year and by 4% since the previous quarter

INCY's EPS has shrunk by 52% YoY but it is up by 15% QoQ

INCY's net income has dropped by 51% year-on-year but it is up by 16% since the previous quarter

What are the main financial stats of INCY

Market
Valuations
Earnings

Shares outstanding

224.11M

Market cap

$12.42B

Enterprise value

$9.23B

Price to earnings (P/E)

29.33

Price to book (P/B)

2.52

Price to sales (P/S)

3.44

EV/EBIT

14.27

EV/EBITDA

12.72

EV/Sales

2.56

Revenue

$3.61B

EBIT

$646.29M

EBITDA

$725.4M

Free cash flow

$580.93M

Per share
Balance sheet
Liquidity

EPS

$1.89

Free cash flow per share

$2.59

Book value per share

$22.01

Revenue per share

$16.11

TBVPS

$27.24

Total assets

$6.39B

Total liabilities

$1.46B

Debt

$31.92M

Equity

$4.93B

Working capital

$3.28B

Debt to equity

0.01

Current ratio

3.91

Quick ratio

3.71

Net debt/EBITDA

-4.41

Margins
Efficiency
Dividend

EBITDA margin

20.1%

Gross margin

93.2%

Net margin

11.8%

Operating margin

13.9%

Return on assets

7%

Return on equity

9.2%

Return on invested capital

38.8%

Return on capital employed

12.3%

Return on sales

17.9%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Incyte stock price performed over time

Intraday

1.11%

1 week

3.82%

1 month

1.58%

1 year

-32.84%

YTD

-30.99%

QTD

-4.05%

How have Incyte's revenue and profit performed over time

Revenue

$3.61B

Gross profit

$3.36B

Operating income

$503.35M

Net income

$424.98M

Gross margin

93.2%

Net margin

11.8%

The net margin has dropped by 55% year-on-year but it is up by 13% since the previous quarter

INCY's net income has dropped by 51% year-on-year but it is up by 16% since the previous quarter

INCY's operating margin is down by 25% year-on-year but it is up by 14% since the previous quarter

Incyte's operating income has decreased by 19% YoY but it has increased by 18% from the previous quarter

What is Incyte's growth rate over time

What is Incyte stock price valuation

P/E

29.33

P/B

2.52

P/S

3.44

EV/EBIT

14.27

EV/EBITDA

12.72

EV/Sales

2.56

INCY's EPS has shrunk by 52% YoY but it is up by 15% QoQ

INCY's P/E is 33% below its 5-year quarterly average of 43.4 and 32% below its last 4 quarters average of 42.6

The stock's price to book (P/B) is 58% less than its 5-year quarterly average of 5.9 and 25% less than its last 4 quarters average of 3.3

INCY's equity is up by 17% year-on-year and by 4% since the previous quarter

INCY's P/S is 48% below its 5-year quarterly average of 6.5 and 23% below its last 4 quarters average of 4.4

Incyte's revenue has increased by 8% YoY and by 2.7% from the previous quarter

How efficient is Incyte business performance

INCY's return on assets has dropped by 58% year-on-year but it is up by 11% since the previous quarter

The ROE has plunged by 58% YoY but it has grown by 12% from the previous quarter

The ROIC has increased by 13% YoY and by 11% from the previous quarter

INCY's ROS is up by 12% QoQ and by 4.1% YoY

What is INCY's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for INCY.

How did Incyte financials performed over time

Incyte's total assets has increased by 16% YoY and by 2.9% from the previous quarter

INCY's total liabilities is up by 13% year-on-year

The debt is 99% smaller than the equity

INCY's equity is up by 17% year-on-year and by 4% since the previous quarter

The debt is down by 5% year-on-year and by 2.2% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.